[Click eStock] "L&K Biomed Expands Global Spine Implant Market...Growth Expected to Accelerate"

On March 12, independent research firm GL Research analyzed that L&K Biomed is highly likely to enter a phase of full-scale revenue growth, driven by the global expansion of its spine implant business, as well as the growth of new products such as height-expandable cages and thoracic implants.

L&K Biomed is a medical device company specializing in the development and sales of spinal and thoracic implants. It primarily focuses on spinal implant products, such as cages and screws, used for the treatment of degenerative spinal diseases. Recently, the company has expanded its product portfolio and strengthened its global market presence through the introduction of its height-adjustable “Expandable Cage” and thoracic implant “Pectus” products.

L&K Biomed’s revenue is expected to grow based on the expansion of spinal implant sales in the United States and the establishment of a global distribution network. Currently, approximately 70% of its revenue is generated in the Americas, and the company is pursuing a strategy to expand its sales regions to Europe, Northeast Asia, and Central and South America, leveraging the references it has secured in the U.S. market. In particular, if contracts with global major distributors are concluded, the sales network is expected to expand significantly, potentially leading to an increase in the number of hospitals supplied and the number of surgeries performed.

L&K Biomed has expanded its business scope into the thoracic treatment market with the FDA approval of its thoracic implant, “CastleLoc Pectus.”

Changyun Park, a researcher at GL Research, stated, “Pectus is a product with a higher average selling price (ASP) compared to existing spinal implants, which will contribute to not only revenue growth but also improved profitability through a better product mix. Currently, the company is expanding its client base, primarily among hospitals in the United States, and if the number of hospitals applying the product increases in the future, revenue growth may accelerate.”

Park further explained, “L&K Biomed is expanding its global sales regions based on the references it has established in the U.S.-centric spinal implant market. As new products such as the Expandable Cage and Pectus continue to grow, the company is highly likely to achieve both top-line growth and improved profitability simultaneously.”

This content was produced with the assistance of AI translation services.